baber/WOPTO huggingface dataset:
Patent EP-0670768-B1 (EP)
Inventor: LUPKE MANFRED ARNO ALFRED
IPC: B29C48/09
Filed: 1993-10-28
Granted: 1997-03-19
Abstract: Dans une grosse installation d'extrusion dans laquelle l'alignment avec l'équipement situé en aval est une nécessité, on a prévu un système de réglage de l'alignement qui permet d'ajuster (34) la position d'une filière (14) d'extrusion par rapport à l'extrudeuse (12). En pratique il est possible d'utiliser une filière à double corps formée de parties (14) dont la première est réglable par rapport à l'autre alors que la deuxième est reliée de manière fixe à l'extrudeuse (12), ou bien une filière en deux parties dont les parties sont réglables l'une par rapport à l'autre. Cette invention peut servir pour aligner une filière d'extrusion par rapport à l'équipement situé en aval tel que de l'outillage, des filières, des tables de calibrage, etc., ainsi que pour former des nervures ou des striures sur des tuyaux à une ou deux parois.
Patent EP-0619863-B1 (EP)
Title: A differential mechanism
Inventor: SPOONER JOHN
IPC: F16H48/12
Filed: 1993-11-08
Granted: 1996-05-29
Abstract: A differential mechanism (10) having two output cam members (22, 23) rotatable about an axis (A) each cam member having a single annular cam surface of undulating form comprising pairs of mutually inclined surfaces (24, 25; 26, 27). The inclined surfaces are engaged by end surfaces (29, 30; 32, 33) of followers (28) so that relative contra rotation of the output cam members (22, 23) causes the cam followers (28) to slide axially. An input element (16) engages and supports the followers and moves the followers circumferentially relative to the output cam members. The input element (16) engages with a radially inner portion (36) of each cam follower to move the follower circumferentially relative to the cam output members (22, 23), and the cam surfaces (24, 25; 26, 27) are inclined (P, P2) away from the axis of rotation (A).
Patent EP-0621673-B1 (EP)
Inventor: MUELLER REINHARD
IPC: H02G5/08
Filed: 1994-03-29
Granted: 1997-01-15
Abstract: In the case of outlet boxes or connection boxes for busbars in low-voltage busbar trunking systems having mounting elements and having a housing which is divided by a partition wall into an equipment area and a connection area, a sliding cover covering either the equipment area or the connection area and being lockable by means of a locking device, it is intended to improve safety and, to be precise, this should be done irrespective of the reliability of the operator. This is achieved in that the mounting elements can be locked by means of a locking device, a bolt of the locking device engaging, when the mounting elements are in the unlocked position, behind the sliding cover in the locking manner. Furthermore, a protection device is provided, which consists of elements or probe fingers which can enter the retaining area between the connecting tab contacts, release the sliding cover when they enter said area and lock the sliding cover when they leave it. <IMAGE>
Patent EP-0643202-B1 (EP)
Inventor: KRUEGER KLAUS
IPC: F02M35/10
Filed: 1994-04-22
Granted: 1997-03-19
Abstract: The flange fastens pipes (1) to an engine block. It has a sealing plate (2), with an aperture (4) for each pipe. The sealing plate is connected to a hood (5), which has apertures coinciding with those in the sealing plate. Hood and plate enclose a sealed hollow chamber (8). Plate and cover have aligned fastening bores (3,9). They may be welded or soldered to each other. The hood is formed as a deep drawn part. It engages flat on the plate, esp. along the edge. The sealing plate has an aperture (12) into the chamber, and the hood has a socket, which also extends into the chamber. The pipe is fastened to plate and hood.
Patent EP-0610056-B1 (EP)
Inventor: PARTYKA DORIS
IPC: A61L15/60
Filed: 1994-02-01
Granted: 2002-06-05
Abstract: A hydrogel dressing is provided which is suitable for adherence to an adhesive coated backing of a bandage. The dressing consists of a layer of hydrogel in face-to-face relationship with a substrate. The hydrogel facing surface of the substrate preferably comprises fibers projecting into the hydrogel and the opposed surface preferably comprises a hydrogel occlusive polymeric film. The hydrogel is crosslinked, in situ, on the substrate and thereby firmly anchors thereto. The occlusive film assures adhesion of the dressing to an adhesive coated bandage backing.
Patent EP-0672145-B1 (EP)
Inventor: BAUER S CHRISTOPHER
IPC: C07K17/00
Filed: 1993-11-22
Granted: 2003-04-23
Abstract: The present invention relates to recombinant human interleukin-3 (hIL-3) variant or mutant proteins (muteins). These hIL-3 muteins contain one or more amino acid substitutions and may also have amino acid deletions at both the N- and C- termini. The invention also relates to pharmaceutical compositions containing the hIL-3 muteins and methods for using them. Additionally, the present invention relates to recombinant expression vectors comprising nucleotide sequences encoding the hIL-3 muteins, related microbial expression systems, and processes for making the hIL-3 muteins using the microbial expression systems. <??>Included in the present invention are deletion mutants of hIL-3 in which from 1 to 14 amino acids have been deleted from the N-terminus, and from 1 to 15 amino acids (corresponding to residues 119 to 133) have been deleted from the C-terminus, and which also contain one to three amino acid substitutions in the polypeptide. These hIL-3 mutant polypeptides may have biological activities similar to or better than hIL-3 and, in some cases, may also have an improved side effect profile.
Patent EP-0677201-B1 (EP)
Title: Eclairage par l'arriere pour affichage a cristaux liquides
Inventor: STRICKLING JAMES E III
IPC: G02F1/13357
Filed: 1993-12-30
Granted: 2002-07-10
Abstract: L'invention se rapporte à un module d'éclairage par l'arrière utilisé dans un dispositif d'affichage électronique (20) à cristaux liquides. Le module comprend une ou plusieurs lampes (38) situées dans une cavité (37) de ce dernier. Les lampes peuvent présenter une large gamme de luminances, y compris une luminance faible obtenue par un agencement de modulation à salve unique permettant d'exciter les lampes.
Patent EP-0690901-B1 (EP)
Inventor: WALLFAHRER UWE HANS
IPC: C10M169/04
Filed: 1994-03-15
Granted: 1998-12-30
Abstract: The invention pertains to a lubricant or lubricant additive having a viscosity ranging from 200 to 1100 cSt which at the same time is compatible with non-polar base fluids such as poly( alpha -olefins), and which comprises a copolymer of an  alpha -olefin having of from 8 to 18 carbon atoms and a fumaric diester having an aliphatic alcohol as the esterifying component, the copolymer having a weight average molecular weight above approximately 3500, and the esterifying component being C8 to C10 alcohol (linear or branched) or iso-C13 alcohol. Also disclosed is a process for the preparation of the copolymers wherein an  alpha -olefin having of from 8 to 18 carbon atoms is reacted with a fumaric diester under the influence of a peroxide radical initiator having tertiary alkyl groups while applying a temperature of from 110  DEG C to 150  DEG C.
Patent EP-0693918-B1 (EP)
Inventor: GRACE WILLIAM RODERICK
IPC: A61K8/36
Filed: 1994-03-16
Granted: 2003-01-08
Abstract: The present invention comprises a non-aerosol shaving composition in the form of a clear gel comprising in percent by weight, with the balance being water, (a) about 15 to 20% of a mixture of potassium myristate and potassium palmitate wherein the myristic acid to palmitic acid ratio is about 2 to 1; (b) about 2 to 4% Oleth-20; (c) about 1 to 5% sodium lauroyl sarcosinate; and (d) about 1 to 2% hydroxyethylcellulose, about 1 to 3% sorbitol, and about 1 to 2% PEG-150 distearate. This composition provides superior shaving attributes compared to other non-aerosol shaving products.
Patent EP-0675924-B1 (EP)
Inventor: ROTH BRUCE L
IPC: C12Q1/68
Filed: 1994-04-13
Granted: 2001-12-12
Abstract: The invention relates to a method of analyzing the viability of a sample of cells using an aqueous solution comprising two fluorescent dyes. Dye I has the formula:   <IMAGE>   where R2 is C1-6 alkyl; Z- is a biologically compatible counterion; X is O; S; Se; or NR15, where R15 is H or C1-6 alkyl; or CR16R17, where R16 and R17, which may be the same or different, are independently H or C1-6 alkyl, or the carbons of R16 and R17 taken in combination complete a five or six membered saturated ring; and the benzazolium is optionally further substituted; n=0, 1, or 2; Y is -CR3=CR4-; p and m=0 or 1, such that p+m=1; R5 is a C1-6 alkyl, C1-6 alkenyl, C1-6 polyalkenyl, C1-6 alkynyl or C1-6 polyalkynyl group; or R5 is an OMEGA; R3, R4, R6 and R7, which may be the same or different, are independently H; or a C1-6 alkyl, C1-6 alkenyl, C1-6 polyalkenyl, C1-6 alkynyl or C1-6 polyalkynyl group; or halogen; or -OR8, -SR8, -(NR8R9), where R8 and R9, which may be the same or different, are independently H; or alkyl groups having 1-6 carbons; or 1-2 substituted or unsubstituted alicyclic, heteroalicyclic, aromatic, or heteroaromatic rings, containing 1-4 heteroatoms, wherein the heteroatoms are O, N, or S; or R8 and R9 taken in combination are -(CH2)2-L-(CH2)2- where L=-O-, -NR10-, -CH2- or a single bond where R10 is H or an alkyl group having 1-6 carbons; or -OSO2R19 where R19 is C1-6 alkyl, or C1-6 perfluoroalkyl, or aryl; or an OMEGA; or R6 and R7, taken in combination are -(CH2)v- where v=3 or 4, or R6 and R7 form a fused aromatic ring that is optionally further substituted; such that at least one of R3, R4, R5, R6 and R7, or a substituent on the aromatic ring formed by R6 and R7, is an OMEGA; where OMEGA is a cyclic substituent that is attached by a single bond. Fluorescent Dye II selectively stains either viable or non-viable cells with a detectable fluorescent response that is different from the fluorescent response of Dye I. The stained cells are illuminated at a suitable absorption wavelength, and the fluorescent response is detected to distinguish viable and non-viable cells based on the fluorescent response.
Patent EP-0697897-B1 (EP)
Inventor: BURCHETT MARK T
IPC: A61J7/00
Filed: 1994-05-11
Granted: 2005-04-06
Abstract: An integrated nursing bottle and liquid medication dispensing apparatus enable precise and independent control of both the rate of administration of the medication, and the amount by which it is diluted before reaching the infant's mouth. The preferred embodiment utilizes a syringe (5) mounted coaxially within a baby bottle (1), allowing one-hand operation.
Patent EP-0696208-B1 (EP)
Title: Oral drug delivery compositions
Inventor: MILSTEIN SAM J
IPC: A61K38/095
Filed: 1994-04-22
Granted: 2001-08-22
Abstract: The present invention relates to an oral drug delivery system, and in particular to modified amino acids and modified amino acid derivatives for use as a delivery system of sensitive agents such as bioactive peptides. The modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form durg containing microspheres. These mixtures are suitable for oral administration of biologically active agents to animals. Methods for the preparation of such amino acids are also disclosed.
Patent EP-0705368-B1 (EP)
Inventor: TALLENTIRE ALAN
IPC: D06M15/693
Filed: 1994-06-08
Granted: 1997-09-17
Abstract: PCT No. PCT/GB94/01236 Sec. 371 Date May 15, 1996 Sec. 102(e) Date May 15, 1996 PCT Filed Jun. 8, 1994 PCT Pub. No. WO94/29525 PCT Pub. Date Dec. 22, 1994A material, which may have a highly open structure such that it has negligible barrier properties, is treated with expandable particles. These are then caused to expand within the material, reducing its openness and improving its barrier properties. The product may be a porous material. The pores may be modified by an agent applied together with the particles or after the expansion. The particles may be thermoplastic microspheres containing gas. The material may be a network material, with a fiber matrix with many voids.
Patent EP-0702725-B1 (EP)
Inventor: ISHIZAKA KIMISHIGE
IPC: C07K19/00
Filed: 1994-05-13
Granted: 2006-07-05
Abstract: Polypeptides, polynucleotides, fragments thereof, and monoclonal antibodies thereto are provided for antigen-specific and antigen-non-specific glycosylation inhibiting factor and a method for recombinant production of biologically active polypeptides from a structural gene encoding the polypeptide.
Patent EP-0722616-B1 (EP)
Inventor: BARTHELMES CLEMENS
IPC: H01J61/82
Filed: 1994-06-30
Granted: 1999-09-08
Abstract: Une lampe à décharge (1) d'halogénure métallique comportant un récipient coaxial de décharge (2) et un tube extérieur (9) est remplie de métaux qui tendent à se diffuser. Leur teneur spécifique est inférieure à 6 νmol/cm3. Les amenées de courant (4, 5) sont entourées sur une grande partie de leur longueur par une gaine (14) qui absorbe le rayonnement ultraviolet.
Patent EP-0793506-B1 (EP)
Inventor: POULETTY PHILIPPE
IPC: A61K47/48
Filed: 1994-09-16
Granted: 2002-04-17
Abstract: Novel bifunctional reagents useful in providing extended in vivo lifetimes of physiologically active agents are provided. The reagents comprise conjugates of a first binding member specific for a target in a mammalian host, such as a toxin, drug of abuse, microbe, autoreactive immune cell, infected or tumourous cell, antigen presenting cell, or the like, joined to a second binding member specific for a long-lived blood component, including cells, such as an erythrocyte, platelet or endothelial cell, and plasma proteins. These conjugates find use by extending the lifetime and availability of the target binding member for coupling the target and the blood component and thereby reducing the concentration free target, modulating the volume of distribution of the target, targeting the target to sites of enhanced immune response, facilitating target clearance from the bloodstream, or extending the stimulation of an immunogen.
Patent EP-0725983-B1 (EP)
Inventor: KLEIN MARTIN
IPC: H01M4/08
Filed: 1994-10-07
Granted: 2003-06-11
Abstract: The subject invention relates to electrode structures that are adaptable for primary and electrically rechargeable electrochemical wafer cells. A flat wafer cell is disclosed that includes conductive, carbon-filled polymeric outer layers that serve as electrode contacts and as a means of containment of the cell. Multi-cell, higher voltage batteries may be constructed by stacking individual cells. Specially formulated electrodes and processing techniques that are compatible with the wafer cell construction are disclosed for a nickel-metal hydride battery system. This invention is further directed to fabrication of electrodes from electrochemically active material prepared by coating non- to low-conductive particles of a metal hydroxide or metal oxide powder with nickel using a electroless nickel coating process. The cell design and electrode formulations provide for individual operation of a vented or low pressure sealed cell and/or for operation of these cells in a stacked array in an outer battery housing. <IMAGE>
Patent EP-0686501-B1 (EP)
Inventor: BERANGER MARIO
IPC: B32B15/08
Filed: 1995-03-15
Granted: 1999-11-24
Abstract: A process for applying a multilayer coating comprising a painlayer and a plastic filmlayer onto a metal coil or plate in which the paintlayer has adhesive properties thereby eliminating the need for a sole adhesive coating step.
Patent EP-0699753-B1 (EP)
Inventor: KOEPSELL HERMANN PROF DR
IPC: G01N33/50
Filed: 1995-07-07
Granted: 2003-06-04
Abstract: A transport protein has been cloned which is present in liver epithelial cells and kidney epithelial cells and in intestinal cells and is responsible for transporting cationic pharmaceuticals and/or xenobiotics. This transport protein has been described more specifically by its DNA and amino acid sequences, and various uses are disclosed which are, in particular, of great importance for developing novel medicaments.
Patent EP-0711515-B1 (EP)
Inventor: CLEMENT JEAN-PIERRE
IPC: A43B5/04
Filed: 1995-10-04
Granted: 1999-05-26
Abstract: The liner, pre-shaped to fit inside a standard boot, has at least one wedging element (5) of thermoplastic foam, pre-shaped by thermo-compression and has micro-perforations (10) to make it more supple and elastically compressible as well as permeable. The wedging element (5) is fitted between the inner (12) and outer (11) walls of the liner. It can be made independent of the liner and attached to either its inner or outer wall, and extend over only a portion of their surfaces.
Patent EP-0687692-B1 (EP)
Inventor: PRICE ALAN GEORGE
IPC: C10G1/10
Filed: 1995-06-02
Granted: 1999-01-27
Abstract: This invention relates to a process for thermally cracking waste polymer(s) comprising chlorinated polymers in a reactor in the presence of a fluidizing gas and a fluidized bed of solid, particulate fluidizable material at a temperature from 350-600 DEG C to cracked products comprising a mixed vapour of lower hydrocarbons which have a chlorine content of less than 50 ppm. In the process, the cracked products emerging from the fluidized bed are passed through one or more guard beds comprising calcium oxide or a compound capable of giving rise to calcium oxide under the reaction conditions maintained at a temperature in the range from 400-600 DEG C. in such a way that the chlorine content of the product is less than 50 ppm. <IMAGE>
Patent EP-0671565-B1 (EP)
Inventor: MEIER PETER
IPC: F16B19/10
Filed: 1995-01-27
Granted: 1998-04-08
Abstract: The grip part (2) of the tool has at least one trough-shaped aperture (2b). The axial length (L) of the aperture corresponds to the length (1) of the dowel. Its wall is curved at a radius, which corresponds to half the external diameter of the dowel. The largest depth of the aperture is at most half the outer dowel diameter, e.g. 0.2 to 0.4 of the diameter. The axial extension of the aperture is parallel to the longitudinal axis of the grip part.
Patent EP-0737452-B1 (EP)
Inventor: PULNEV SERGEI APPOLONOVICH
IPC: A61F2/90
Filed: 1994-12-23
Granted: 2003-10-22
Abstract: A stent in the form of a three-dimensional body consists of interwoven threads (1) arranged as multiple turns in a helix. The threads (1) are arranged in at least two groups (2 and 3) of turns in the helix, having opposite directions of rotation. The ends of the stent (5) consist of zones for the transition of the turns of one helix into the turns of the other helix, which are formed from a single length of thread.
Patent EP-0744034-B1 (EP)
Inventor: HARRINGTON JAMES A
IPC: G02B6/032
Filed: 1995-01-10
Granted: 2006-06-07
Abstract: A rugged flexible hollow-fiber waveguide that permits preservation of good transverse spatial coherence of input infrared laser radiation and that transmits substantial power of such radiation, with low attenuation. The present invention preferably comprises a small-diameter thin-wall silica-glass tube; a protective coating on the outer surface of the tube; a sufficient reflective layer on the inner surface of the tube; and a thickness, optimal for the wavelength(s) of interest, of dielectric on the exposed surface of the reflective layer.
Patent EP-0739364-B1 (EP)
Title: Traitement continu d'aminolyse de copolymeres d'ethylene
Inventor: WANG JAMES H
IPC: C08F8/32
Filed: 1995-01-13
Granted: 1998-04-01
Abstract: On décrit un traitement continu d'aminolyse de polymères obtenus à l'aide d'unités structurelles insaturées en éthylène, comprenant la mise en contact dans une cuve de réaction; (a) d'un polymère fondu contenant des unités structurelles obtenues dans une cuve de réaction à l'aide d'alpha-oléfines possédant de 2 à 8 atomes et d'esters d'acides carboxyliques α,β, insaturés en éthylène; et (b) d'une phase liquide comprenant un composé contenant une amine, par exemple une alkylamine possédant un groupe alkyle contenant de 1 à 30 atomes de carbone, ammoniac ou un dérivé de celui-ci, en présence (c) d'une quantité efficace de catalyseur qui est de préférence une solution contenant un métal, pendant un temps suffisant (environ moins d'une heure) pour obtenir un polymère contenant des unités structurelles acrylamides. Ce traitement est réalisé en continu dans une cuve de réaction, de préférence dans au moins une extrudeuse de réaction, dans des conditions permettant d'obtenir un copolymère contenant des unités structurelles acrylamides.
Patent EP-0751860-B1 (EP)
Title: Method and device for manufacturing biaxially oriented tubing from thermoplastic material
Inventor: PRENGER JAN HENDRIK
IPC: B29C48/90
Filed: 1995-03-17
Granted: 1998-12-16
Abstract: PCT No. PCT/NL95/00098 Sec. 371 Date Nov. 22, 1996 Sec. 102(e) Date Nov. 22, 1996 PCT Filed Mar. 17, 1995 PCT Pub. No. WO95/25626 PCT Pub. Date Sep. 28, 1995Method and devices for manufacturing biaxially oriented tubing from thermoplastic material. The method includes forcing the tube over a mandrel at an orientation temperature of the plastic material, which mandrel includes an expansion part which produces expansion in the circumferential direction of the tube. The forcing over the mandrel is achieved by exerting a pushing force on the tube upstream of the expansion part of the mandrel by a pushing device acting upon the outside of the tube, and by exerting a pulling force on the tube downstream of the mandrel. The pushing device acts upon the tube at a distance upstream of the mandrel, and the tube is supported between the place where said pushing device acts and the expansion part of the mandrel.
Patent EP-0856017-B1 (EP)
Inventor: CHANG MOH-CHING OLIVER
IPC: C08F265/04
Filed: 1995-05-16
Granted: 2003-04-16
Abstract: L'invention se rapporte à une composition polymérique qui comprend (A) un premier substrat greffé en caoutchouc de type acrylate; (B) un second substrat greffé en caoutchouc de type acrylate; et (C) une matrice dans laquelle au moins l'un des substrat en caoutchouc de type acrylate est un copolymère comprenant de 83 à 98 %, en poids, de monomère acrylique, et de 17 à 2 %, en poids, de monomère de nitrile non saturé, par rapport au poids total du caoutchouc copolymérique acrylate-acrylonitrile.
Patent EP-0769024-B1 (EP)
Inventor: REPPERT STEVEN M
IPC: A61K31/40
Filed: 1995-06-07
Granted: 2005-11-09
Abstract: Disclosed are cDNAs and DNAs encoding high-affinity melatonin 1a and 1b receptors and the recombinant polypeptides expressed from such cDNAs. The recombinant receptor polypeptides, receptor fragments and analogs expressed on the surface of cells are used in methods of screening candidate compounds for their ability to act as agonists or antagonists to the effects of interaction between melatonin and high-affinity melatonin receptor. Agonists are used as therapeutics to reentrain endogenous melatonin rhythms as a means of treating circadian rhythm disorders in humans and control reproductive cycles in seasonally breeding animals. Antagonists are used as therapeutics to control the initiation or timing of puberty in humans. Antibodies specific for a high-affinity melatonin receptor (or receptor fragment or analog) and their use as a therapeutic are also disclosed.